Covaxin Phase 1 Trial Clears Lancet Review - The Sikh Times
Politics

Covaxin Phase 1 Trial Clears Lancet Review

New Delhi: 22 Jan 21 Covaxin, India’s first indigenous vaccine against COVID-19, showed enhanced immune response without any serious side effects in the Phase 1 trials, according to the results published in well-respected Lancet Infectious Disease journal on Friday.Similar peer-reviewed studies for the Phase 2 are still awaited and Phase 3 trials are ongoing even as the government continues to give out the jabs to lakhs of front-line workers. While the first two phases of vaccine trials usually focus on their safety, the third stage generally determines its efficacy.

Related posts

CBI free to take action against Mamata Banerjee : SC

thesikh

Uddhav Thackeray-Led Alliance Shows How To Defeat BJP

thesikh

Multi-Model Logistics Park In Assam’s Silchar, Nitin Gadkari Announces

thesikh

Home Minister Amit Shah was on a two-day tour of West Bengal

thesikh

High Court Rejects Actor Sonu Sood’s Plea Against Illegal Construction Notice

thesikh

Haryana Chief Minister “unwanted” Khalistani elements being part of the farmer protests.

thesikh

Leave a Comment